Search results
Shareholders in Oramed Pharmaceuticals (NASDAQ:ORMP) have lost 58%, as stock drops 22% this past...
Simply Wall St. via Yahoo Finance· 2 years agoInvesting in stocks comes with the risk that the share price will fall. And there's no doubt that...
Oramed Pharmaceuticals (NASDAQ:ORMP) shareholders have earned a 27% CAGR over the last three years
Simply Wall St. via Yahoo Finance· 2 years agoWhile Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) shareholders are probably generally happy, the stock...
Oramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year...
Simply Wall St. via Yahoo Finance· 7 months agoInvesting in stocks comes with the risk that the share price will fall. And there's no doubt that...
Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 months agoOramed Pharmaceuticals (NASDAQ:ORMP) Full Year 2023 Results Key Financial Results Net income:...
Oramed Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 1 year agoOramed Pharmaceuticals (NASDAQ:ORMP) Third Quarter 2022 Results Key Financial Results Net loss:...
Oramed Pharmaceuticals (NASDAQ:ORMP) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 10 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
Oramed Oral Insulin Shows Evidence For NASH Treatment
Benzinga via Yahoo Finance· 2 years agoOramed Pharmaceuticals Inc (NASDAQ: ORMP) announced Phase 2 results from its trial of its oral...
Oramed Pharma Shares Fall After Additional Data From Oral Insulin Study
Benzinga via Yahoo Finance· 1 year agoOramed Pharmaceuticals Inc (NASDAQ: ORMP) has announced additional data from its Phase 2 trial...
Oramed Pharmaceuticals' Oral COVID-19 Vaccine Candidate Shows Safety, Immunogenicity In Early Study
Benzinga via Yahoo Finance· 2 years agoOramed Pharmaceuticals Inc's (NASDAQ: ORMP) subsidiary, Oravax Medical Inc, reported preliminary...
Oramed Pharma Shares Sink After Diabetes Candidate Fails In Phase 3 Study
Benzinga via Yahoo Finance· 1 year agoOramed Pharmaceuticals Inc (NASDAQ: ORMP) announced top-line results from its Phase 3 trial...